Journal of Cardiovascular Pharmacology · 2007 · 98 citations · 20 references
MedicineCardiologyPharmacologyBiochemical PharmacologyMolecular PharmacologyPharmacodynamicsCardiovascular DiseaseCardiovascular Molecular PhysiologyCardiovascular PharmacologyEndothelial DysfunctionOxidative StressReactive Oxygen SpeciesMitogen-activated Protein Kinase KinaseOxidative Stress In Cardiovascular DiseaseOxidative Stress InjuryP38 Mitogen-activated Protein Kinase SignalingReactive Oxygen Species GenerationReactive Oxygen Species InjuryReactive Oxygen Species SignalingVascular Endothelial Dysfunction
Angiotensin II (Ang II) activates p38 mitogen-activated protein kinase (p38 MAPK) and increases reactive oxygen species (ROS), but the nature of the relationship in vivo is not fully understood. We assess the effect of SB239063AN, a highly selective, orally active, p38 MAPK inhibitor, on Ang II-dependent hypertension, target-organ damage and ROS production. Sprague-Dawley rats and MAPKAP kinase-2 knockout mice were infused with Ang II. Ang II infusion increased the levels of phosphorylated p38 MAPK in the heart and aorta. Production of superoxide anion and expression of NAD(P)H oxidase subunit gp91 in the aorta were increased 4- and 5-fold, respectively. In addition, Ang II infusion led to endothelial dysfunction, progressive and sustained hypertension, and cardiac hypertrophy. Treatment with SB239063AN (800 ppm in the diet) significantly attenuated the levels of phosphorylated p38 MAPK in the heart and aorta, reduced superoxide anion generation by 57% (P < 0.01), markedly suppressed gp91 mRNA expression, prevented endothelial dysfunction, and blunted both the hypertension and cardiac hypertrophy. Ang II-dependent hypertension was also significantly attenuated in MAPKAP kinase-2 knockout mice. The results suggest that Ang II induced hypertension, organ damage, and ROS production are possibly mediated by p38 MAPK and inhibition of p38 MAPK may offer a therapeutic approach for cardiovascular disease.
20
Chris Heid, Junko Stevens, Kenneth J. Livak et al. · Genome Research · 1996 · 6.2K citations · Full text
Sanjay Rajagopalan, Stephan Kurz, Thomas Münzel et al. · Journal of Clinical Investigation · 1996 · 2.4K citations · Full text
Masuko Ushio‐Fukai, R. Wayne Alexander, Marjorie Akers et al. · Journal of Biological Chemistry · 1998 · 653 citations · Full text
MAPKK-Independent Activation of p38α Mediated by TAB1-Dependent Autophosphorylation of p38α
Baoxue Ge, Hermann Gram, Franco Di Padova et al. · Science · 2002 · 524 citations